Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

LncRNA018392 helps goat skin cells grow by increasing CSF1R.

IL10_ApoEVs improve skin healing and reduce scarring.

Type I interferons play a key role in the development of various skin diseases.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

IL-17 and IL-23 inhibitors may cause hair loss.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

IL-27 may help prevent hair loss in alopecia areata by promoting immunosuppressive T cells.

Notch1 helps skin heal by attracting cells that aid repair.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

The harlequin ichthyosis mouse mutation causes thick skin and early death, resembling a human skin disorder.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Certain immune cells, when activated by specific signals, can encourage hair growth.